MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2022-23)
- Udyam number
- UDYAM-MH-19-0189276
Starnox Pharma India Private Limited
Starnox Pharma India Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
Revenue · FY 2025
₹53.82 Lakh
▼ 17% YoY
Net profit · FY 2025
₹43,000
Net margin 0.8%
EBITDA · FY 2025
₹88,000
EBITDA margin 1.6%
Authorised capital
₹10 Lakh
Registered with MCA
Paid-up capital
₹10 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
About Starnox Pharma India Private Limited
Data last updated:
Starnox Pharma India Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 November 2022.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2022PTC394169. Its GSTIN is 36ABJCS8110Q1ZQ (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹10 Lakh. It is led by directors Ramesh Satu and Gajula Surya Prakash.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Mumbai, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹53.82 Lakh, a decline of 17% compared to the previous year. For the same year it recorded a net profit of ₹43,000 (net margin 0.8%) and EBITDA of ₹88,000 (EBITDA margin 1.6%).
Starnox Pharma India Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-MH-19-0189276).
Company details
CIN U24230MH2022PTC394169
Registration Number 394169
Incorporation Date 25 November 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Micro
Udyam Registration UDYAM-MH-19-0189276
Recognitions & Rankings of Starnox Pharma India
Contact details
Starnox Pharma India Private Limited's registered office is in Mumbai, Maharashtra.
- Registered AddressFlatno 103 Saraswati Building Thakur Vlg, Vasanth Sagar B Wing Kandivali, Mumbai, Maharashtra, India – 400101
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Starnox Pharma India Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Starnox Pharma India is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Starnox Pharma India Private Limited, buy the company report.
Financials of Starnox Pharma India Private Limited
FY 2025 filings availableStarnox Pharma India Private Limited reported revenue of ₹53.82 Lakh (down 17% YoY) for FY 2025.
Revenue · FY 2025
₹53.82 Lakh ▼ 17%
Net profit · FY 2025
₹43,000 margin 0.8%
EBITDA · FY 2025
₹88,000 margin 1.6%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 17%
EBITDA CAGR growth
1 year
▼ 34%
Revenue fell 17% in the latest year. EBITDA fell 34% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | |||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹88,000 | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | ₹43,000 | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 1.6% | ||
| Net Profit Margin | 0.8% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Starnox Pharma India Private Limited, buy the company report.
Board of directors of Starnox Pharma India Private Limited
Starnox Pharma India has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ramesh Satu | Director | 25 Nov 2022 | 3 Years 11 Months | Current |
| Gajula Surya Prakash Also directs: Knox Constructions Private Limited | Director | 25 Nov 2022 | 3 Years 11 Months | Current |
Peer comparison
Starnox Pharma India Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Safe Climber Overseas Private Limited | ₹53.88 Lakh (FY 2024) | Mumbai, Maharashtra, India | ||||
| Mahogany Organics Private Limited | ₹53.88 Lakh (FY 2024) | 94.0% | Dehradun, Uttarakhand, India | |||
| Bchemix Private Limited | ₹53.87 Lakh (FY 2025) | 176.0% | Chennai, Tamil Nadu, India | |||
| Phytobiox Manufactures Private Limited | ₹53.84 Lakh (FY 2024) | -68.0% | Bhubaneswar, Odisha, India | |||
| Eurasian Coating Paint Manufacturing and Chemical Trading Private Limited | ₹53.84 Lakh (FY 2022) | 475.0% | Ghaziabad, Uttar Pradesh, India | |||
| Starnox Pharma India Private Limitedthis company | ₹53.82 Lakh (FY 2025) | ₹43,000 | 0.8% | -17.0% | Mumbai, Maharashtra, India | |
| Cropvin Agri Private Limited | ₹53.75 Lakh (FY 2023) | -27.0% | Hyderabad, Telangana, India | |||
| Revex Industries Private Limited | ₹53.74 Lakh (FY 2025) | -78.0% | New Delhi, Delhi, India | |||
| Wellgo Life Farms Private Limited | ₹53.73 Lakh (FY 2018) | 613.0% | Chennai, Tamil Nadu, India | |||
| Evantas Biotec Private Limited | ₹53.7 Lakh (FY 2022) | 47.0% | Bengaluru, Karnataka, India | |||
| Berrys Health Care Private Limited | ₹53.7 Lakh (FY 2024) | 28.0% | Hubli580030, Karnataka, India |
To see the full peer comparison of Starnox Pharma India Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Starnox Pharma India Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Starnox Pharma India Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Starnox Pharma India has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36ABJCS8110Q1ZQ | Telangana | Active | 01 Dec 2022 |
To see the full GST registrations and return filing status of Starnox Pharma India Private Limited, buy the company report.
Recent activity
Starnox Pharma India Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Gajula Surya Prakash was appointed as Director on 25 Nov 2022.
AGM
Starnox Pharma India Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Starnox Pharma India Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai.
Appointed
Gajula Surya Prakash was appointed as Director.
Appointed
Ramesh Satu was appointed as Director.
Incorporation
25 Nov 2022
Starnox Pharma India Private Limited was registered on 25 Nov 2022 with Roc Mumbai & aged 3 years 11 months as per MCA records.
Frequently asked questions
Starnox Pharma India is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 25 November 2022 (4+ years old) and is registered under CIN U24230MH2022PTC394169.
Starnox Pharma India has 2 current directors:
- Ramesh Satu - Director
- Gajula Surya Prakash - Director
The latest financial statements of Starnox Pharma India on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.
The GSTIN of Starnox Pharma India is 36ABJCS8110Q1ZQ, registered in Telangana.
The CIN (Corporate Identification Number) of Starnox Pharma India is U24230MH2022PTC394169. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Starnox Pharma India was incorporated on 25 November 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Starnox Pharma India by revenue are Safe Climber Overseas Private Limited, Mahogany Organics Private Limited, Bchemix Private Limited, Phytobiox Manufactures Private Limited, Eurasian Coating Paint Manufacturing and Chemical Trading Private Limited and 5 more, all in the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Gajula Surya Prakash was appointed as Director on 25 Nov 2022. Ramesh Satu was appointed as Director on 25 Nov 2022.
Yes, Starnox Pharma India is registered as a micro enterprise under Udyam registration (number: UDYAM-MH-19-0189276).
The registered office of Starnox Pharma India is at Flatno 103 Saraswati Building Thakur Vlg, Vasanth Sagar B Wing Kandivali, Mumbai, Maharashtra, India – 400101.
Starnox Pharma India operates in the pharma industry, in the drug formulation and development segment.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
Swiggy Limited Listed company · 92 pages
BharatPe (Resilient Innovations Pvt Ltd) Unlisted company · 78 pages